NEW YORK (WWTI) — The U.S. Food and Drug Administration has issued warning letters to website operators for the illegal sale of opioids.
According to the FDA, 17 website operators violated the Federal Food, Drug and Cosmetic Act through the sale of unapproved and misbranded opioids online. Products being sold included tramadol and oxycodone.
The FDA stated that that warning letters were sent to the following companies:
- Thomas Meds
“Those who illegally sell opioids online put consumers at risk and undermine the significant strides we have made to combat the opioid crisis,” said Director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research Donald D. Ashley. “We remain committed to using all available tools to stop the illegal sale of opioids online to help protect consumers from these potentially dangerous products.”
Additionally, the FDA warned consumers of the highly addictive risks causing misuse and abuse.
For more information, visit the FDA website.
- More than one million dollars paid by NY restaurants, bars for COVID-19 violations
- Schenectady announces 2021 proposed budget, predicts $12m COVID-19 related shortfall
- Shen field hockey returning plenty of firepower for 2020 season
- Bills QB Josh Allen and OC Brian Daboll bond over their highly competitive nature
- ‘Cash for Coats’ drive launched in Albany